A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)
Condition: Progressive Supranuclear Palsy Interventions: Drug: UCB0107; Drug: Placebo Sponsor: UCB Biopharma S.P.R.L. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials